Related Experiment Video
Updated: Jul 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Clinical inquiries: What blood tests help diagnose celiac disease?
Bonzo K Reddick1, Karen Crowell, Belinda Fu
1Department of Family Medicine, University of North Carolina, Chapel Hill, NC, USA.
Insights
Diagnosing celiac disease relies on small bowel biopsy. However, serum antibody tests like IgA tTG and IgA EMA can identify patients needing a biopsy, though IgA deficiency can cause false negatives.
Area of Science:
- Gastroenterology and Immunology
- Celiac Disease Diagnostics
Background:
- Small bowel biopsy is the definitive method for diagnosing celiac disease.
- Non-invasive serological tests are crucial for identifying individuals who may benefit from biopsy.
Purpose of the Study:
- To evaluate the utility of serum antibody assays as initial screening tools for celiac disease.
- To compare the diagnostic accuracy of various antibody tests, including IgA tTG, IgA EMA, IgA AGA, and IgG AGA.
Main Methods:
- Review of existing literature, including systematic reviews and cross-sectional studies.
- Analysis of the performance of four key serum antibody assays in identifying potential celiac disease patients.
Main Results:
- Immunoglobulin A tissue transglutaminase (IgA tTG) and IgA endomysial antibody (IgA EMA) demonstrate the highest diagnostic accuracy among the tested assays.
- Selective IgA deficiency can lead to false-negative results in IgA-based antibody assays.
Conclusions:
- IgA tTG and IgA EMA are recommended as the most accurate first-line serological tests for celiac disease screening.
- Clinicians should consider the possibility of selective IgA deficiency when interpreting negative IgA antibody results.
Abstract:
Histological confirmation of infiltrative lesions via small bowel biopsy is the gold standard for diagnosing celiac disease. Four serum antibody assays may serve as a first-step diagnostic tool to identify biopsy candidates: immunoglobulin A tissue transglutaminase (IgA tTG), IgA endomysial antibody (IgA EMA), IgA antigliadin antibody (IgA AGA), and IgG antigliadin antibody (IgG AGA). IgA tTG and IgA EMA offer the best diagnostic accuracy. Patients with selective IgA deficiency may have falsely negative IgA assays (strength of recommendation [SOR]: B, based on a systematic review, multiple small cross-sectional studies, and expert opinion).
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...